Product NDC: | 47781-265 |
Proprietary Name: | Oxycodone hydrochloride |
Non Proprietary Name: | Oxycodone hydrochloride |
Active Ingredient(s): | 30 mg/1 & nbsp; Oxycodone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47781-265 |
Labeler Name: | Alvogen, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202116 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120112 |
Package NDC: | 47781-265-01 |
Package Description: | 100 TABLET in 1 BOTTLE (47781-265-01) |
NDC Code | 47781-265-01 |
Proprietary Name | Oxycodone hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE (47781-265-01) |
Product NDC | 47781-265 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Oxycodone hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120112 |
Marketing Category Name | ANDA |
Labeler Name | Alvogen, Inc. |
Substance Name | OXYCODONE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |